RCC |
|
KLF2 |
Induce |
Suppress proliferation, migration and invasion abilities of RCC cells |
In vitro and in vivo |
[29] |
|
|
AIM2 |
Inhibit |
Promote RCC progression and sunitinib resistance |
In vitro and in vivo |
[39] |
|
|
MLYCD |
Induce |
Reduce tumor growth and reverse resistance to sunitinib |
In vitro and in vivo |
[43] |
|
|
OGT |
Induce |
Promote the proliferation, clone formation, and invasion of VHL-mutated ccRCC cells |
In vitro and in vivo |
[48] |
|
|
Knockdown of SETD2 |
Induce |
Promote tumor cell death |
In vitro and in vivo |
[103] |
|
|
STEAP3 |
Inhibit |
Poor survival and prognosis |
In vitro |
[104] |
|
RSL3 or Erastin |
|
Induce |
Overcome resistance to everolimus |
In vitro |
[105] |
|
MIL-101(Fe)@RSL3 |
|
Induce |
|
In vitro and in vivo |
[107] |
|
|
NCOA4 |
Induce |
Maintain ferritinophagy |
In vitro and in vivo |
[108, 109] |
|
|
CX3CL1 |
Induce |
Inhibit tumor cell proliferation and metastasis |
In vitro and in vivo |
[110] |
PCa |
Flubendazole |
|
Induce |
Inhibit cell proliferation,cause cell cycle arrest in G2/M phase and promoted cell death |
In vitro and in vivo |
[51] |
|
|
PHGDH |
Inhibit |
Promote cell growth and Enza resistance in CRPC cells |
In vitro and in vivo |
[56] |
|
TQB3720 |
|
Induce |
Inhibit the growth of prostate cancer |
In vitro and in vivo |
[59] |
|
|
AOC1 |
Induce |
Reduce proliferation and migration in prostate cancer |
In vitro and in vivo |
[67] |
|
Erastin or RSL3 |
|
Induce |
Halt prostate cancer cell growth and migration in vitro and tumor growth in vivo |
In vitro and in vivo |
[111] |
|
Icariin and curcumol |
|
Induce |
Induce autophagy in PCa cells |
In vitro and in vivo |
[113] |
|
Ferumoxytol |
|
Induce |
Enhance NK cells’ function |
In vitro and in vivo |
[114] |
BCa |
NCT-502 |
PHGDH |
Inhibit |
Induce tumor progression |
In vitro and in vivo |
[69] |
|
|
EMP1 |
Induce |
Suppress tumor cell metastasis |
In vitro and in vivo |
[70] |
|
BQR@MLipo |
|
Induce |
Trigger ferroptosis of bladder cancer |
In vitro and in vivo |
[74] |
|
|
FLRT2 |
Induce |
Suppress tumor cell growth, migration and invasion |
In vitro |
[76] |
|
Abietic acid (AA) |
|
Induce |
Selectively inhibited the viability of BC cells |
In vitro and in vivo |
[78] |
|
|
RP11-89 |
Inhibit |
Promote cell proliferation, migration and tumorigenesis and inhibited cell cycle arrest |
In vitro and in vivo |
[117] |
|
|
LUCAT1 |
Inhibit |
Foster cell proliferation, migration, and invasion |
In vitro and in vivo |
[119] |
|
Evodiamine |
|
Induce |
Suppress the migratory ability, decreas the expression of mesenchymal markers, and increase epithelial marker expression |
In vitro and in vivo |
[120] |